Quantcast

Latest Destination Therapy Stories

2014-09-16 23:04:08

Former Major League Baseball relief pitcher Kent Tekulve is recovering well today after undergoing successful heart transplantation surgery at Allegheny General Hospital (AGH) on Friday, September 5. Pittsburgh, PA (PRWEB) September 16, 2014 Former Major League Baseball relief pitcher Kent Tekulve is recovering well today after undergoing successful heart transplantation surgery at Allegheny General Hospital (AGH) on Friday, September 5. Mr. Tekulve, who spent most of his 16-year baseball...

2014-09-09 16:26:44

PLEASANTON, Calif., Sept. 9, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun to enroll patients in the HeartMate III(TM) U.S. clinical trial. "We are excited to continue our recent pipeline progress with the start of the U.S. clinical trial for HeartMate III," said Gary F. Burbach, President and Chief Executive Officer....

2014-09-04 23:02:54

Memorial Regional Hospital is only one of two Ventricular Assisted Device programs now serving the South Florida community. Hollywood, Fl (PRWEB) September 04, 2014 Memorial Regional Hospital, a leading provider of adult cardiac services in Florida, recently earned The Joint Commission’s Gold Seal of Approval for its ventricular assist device (VAD) destination therapy program, offered through its Memorial Cardiac and Vascular Institute. Memorial Regional Hospital is the first hospital...

2014-08-05 08:35:27

FRAMINGHAM, Mass., Aug. 5, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 34th Annual Growth Conference at 9:00 a.m. EDT on Thursday, August 14, 2014. The conference is being held August 13-14 at the InterContinental Boston. A...

2014-06-12 08:30:38

FRAMINGHAM, Mass., June 12, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Wells Fargo Healthcare Conference at 4:40 p.m. EDT on Tuesday, June 17, 2014. The conference is being held June 17-18 at the InterContinental Boston. A live webcast of...

2014-06-06 08:25:15

FRAMINGHAM, Mass., June 6, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Goldman Sachs 35(th) Annual Global Healthcare Conference at 10:00 a.m. PDT (1:00 p.m. EDT) on Thursday, June 12, 2014. The conference is being held June 10-12 at the Terranea...

2014-06-03 16:25:02

FRAMINGHAM, Mass., June 3, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the William Blair & Company 34(th) Annual Growth Stock Conference at 4:10 p.m. CDT (5:10 p.m. EDT) on Tuesday, June 10, 2014. The conference is being held June 10-12 at the...

2014-05-09 08:26:52

FRAMINGHAM, Mass., May 9, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care Conference at 12:00 p.m. PDT (3:00 p.m. EDT) on Tuesday, May 13, 2014. The conference is being held May 12-15 at the Encore at...

2014-03-18 08:31:41

SynCardia Systems, Inc. Continues to Make Progress for Approval of the SynCardia Heart for Permanent Use to Save Patients Who Are Unlikely to Receive Another Donor Heart TUCSON, Ariz., March 18, 2014 /PRNewswire/ -- SynCardia Systems, Inc. is moving forward to gain FDA approval to use the SynCardia temporary Total Artificial Heart as destination therapy (a permanent replacement heart), which could save patients whose donor heart transplant is failing and are unlikely to receive another...

2014-03-11 16:26:25

Once Results of Studies Are Approved by the FDA, the Smaller 50cc SynCardia Heart and New Permanent Use Indication Will Triple the Number of Heart Failure Patients Who Can Get a 2nd Chance at Life TUCSON, Ariz., March 11, 2014 /PRNewswire/ -- Recent developments surrounding the SynCardia temporary Total Artificial Heart will make the life-saving device available to three times the number of people suffering from end-stage biventricular heart failure. Over 300 SynCardia Hearts have...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related